CNR Institutional Research Information System

LAEZZA, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 570
AS - Asia 104
EU - Europa 23
Totale 697
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 570
SG - Singapore 99
IT - Italia 19
FI - Finlandia 3
CN - Cina 2
AE - Emirati Arabi Uniti 1
HK - Hong Kong 1
JP - Giappone 1
NL - Olanda 1
Totale 697
Salva come PNG Salva come JPEG
Città #
Santa Clara 549
Singapore 60
Helsinki 3
Naples 3
Fisciano 2
Rome 2
Amsterdam 1
Ashburn 1
Avellino 1
Hong Kong 1
Seattle 1
Tokyo 1
Totale 625
Salva come PNG Salva come JPEG
Nome #
Cholesterol Homeostasis Modulates Platinum Sensitivity in Human Ovarian Cancer. 13
Immuno-modulatory and anti-inflammatory effects of dihydrogracilin a, a terpene derived from the marine sponge Dendrilla membranosa 13
The endocannabinoid system: A target for cancer treatment 12
The CB1 receptor antagonist rimonabant controls cell viability and ascitic tumour growth in mice. 11
Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor 11
Deregulated expression and activity of Farnesyl Diphosphate Synthase (FDPS) in Glioblastoma 11
N6-Isopentenyladenosine Enhances the Radiosensitivity of Glioblastoma Cells by Inhibiting the Homologous Recombination Repair Protein RAD51 Expression 11
Lovastatin induces apoptosis of k-ras-transformed thyroid cells via inhibition of ras farnesylation and by modulating redox state. 10
Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis. 10
Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin. 10
Reply to the letter to the editor 10
Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response. 10
Endocannabionoid System in Neurological Disorders. 10
Inhibitory effects of cannabinoid CB 1 receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasis. 10
Anti Proliferative and Pro Apoptotic Effects of Flavonoid Quercetin Are Mediated by CB1 Receptor in Human Colon Cancer Cell Lines. 10
Effects of anandamide on polyamine levels and cell growth in human colon cancer cells. 10
N6-isopentenyladenosine arrests tumor cell proliferation by inhibiting farnesyl diphosphate synthase and protein prenylation. 10
Cannabidiol: State of the art and new challenges for therapeutic applications 10
Anandamide Drives Cell Cycle Progression through CB1 Receptors in a Rat Model of Synchronized Liver Regeneration. 10
Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation. 10
Rimonabant reduces keratinocyte viability by induction of apoptosis and exerts topical anti-inflammatory activity in mice. 9
Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer. 9
Antitumor effect of pyrrolo-1,5-benzoxazepine-15 and its synergistic effect with Oxaliplatin and 5-FU in colorectal cancer cells. 9
Novel role for cannabidiol in circadian clock function 9
Immuno-modulatory Properties of a Quinolin-2-(1H)-on-3-carboxamide Derivative: Relevance in Multiple Sclerosis. 9
The anandamide analogue, Met-F-AEA, controls human breast cancer cell migration via the RhoA/Rho kinase signaling pathway. 9
p53 regulates the mevalonate pathway in human glioblastoma multiforme. 9
N6-isopentenyladenosine inhibits colorectal cancer and improves sensitivity to 5-fluorouracil-targeting FBXW7 tumor suppressor 9
Involvement of Akt/NF-ºB pathway in N6-isopentenyladenosine-induced apoptosis in human breast cancer cells. 9
Energy metabolism in glioblastoma stem cells: PPAR? a metabolic adaptor to intratumoral microenvironment 9
Estrogenic induction of cannabinoid CB1 receptor in human colon cancer cell lines. 9
Recognition by natural killer cells of N6-isopentenyladenosine-treated human glioma cell lines 9
Rimonabant (SR141716) induces metabolism and acquisition of fertilizing ability in human sperm. 9
Rimonabant (SR141716) exerts anti-proliferative and immunomodulatory effects in human peripheral blood mononuclear cells. 9
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells. 9
The Cannabinoid CB1 Receptor Antagonist Rimonabant (SR141716) Inhibits Human Breast Cancer Cell Proliferation through a Lipid Raft-Mediated Mechanism. 9
Immunomodulatory properties of 1,2-dihydro-4-hydroxy-2-oxo-1,8-naphthyridine-3-carboxamide derivative VL15 9
N6-isopentenyladenosine dual targeting of AMPK and Rab7 prenylation inhibits melanoma growth through the impairment of autophagic flux 9
The N-Terminal Domain of 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase Harbors a GTP/ATP Binding Site. 9
Human Sperm Anatomy: Ultrastructural Localization of the Cannabinoid1 Receptor and a Potential Role of Anandamide in Sperm Survival and Acrosome Reaction. 9
Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: an investigation of the 1,8-naphthyridin-2(1H)-one scaffold. 9
Interaction of endocannabinoid system and steroid hormones in the control of colon cancer cell growth. 9
The isoprenoid derivative N6-benzyladenosine (CM223) exerts antitumor effect in glioma patient-derived primary cells through the mevalonate pathway. 9
Antitumor effect of pyrrolo-1,5-benzoxazepine-15 and its synergistic effect with Oxaliplatin and 5-FU in colorectal cancer cells. 9
Plasma membrane and lysosomal localization of CB1 cannabinoid receptor are dependent on lipid rafts and regulated by anandamide in human breast cancer cells. 8
Anandamide inhibits adhesion and migration of breast cancer cells. 8
Antiangiogenetic activity of the endocannabinoid anandamide.Correlation to its tumour-suppressor efficacy 8
Estrogenic regulation of cholesterol biosynthesis and cell growth in DLD-1 human colon cancer cells. 8
Higher farnesyl diphosphate synthase activity in human colorectal cancer inhibition of cellular apoptosis. 8
Rimonabant reduces keratinocyte viability by induction of apoptosis and exerts topical anti-inflammatory activity in mice. 8
Arvanil and anandamide up-regulate CD36 expression in human peripheral blood mononuclear cells. 8
PPAR? Antagonist AA452 Triggers Metabolic Reprogramming and Increases Sensitivity to Radiation Therapy in Human Glioblastoma Primary Cells 8
Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents. 8
Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells. 8
Update on the endocannabinoid system as an anticancer target. 8
Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon 8
N6-isopentenyladenosine, an endogenous isoprenoid end product, directly affects cytotoxic and regulatory functions of human NK cells through FDPS modulation. 8
Endocannabinoids in endocrine and related tumours. 8
1,2-Dihydro-2-oxopyridine-3-carboxamides: The C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptor. 8
A new role of anandamide in human sperm: focus on metabolism. 8
Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis. 8
N6-isopentenyladenosine improves nuclear shape in fibroblasts from humans with progeroid syndromes by inhibiting the farnesylation of prelamin A. 8
Association between Cannabinoid type-1 receptor polymorphism and body mass index in a Southern Italian population. 8
Endocannabinoids as emergine suppressors of angiogenesis and tumor invasion 8
The endocannabinoid signaling system in cancer. 8
Cannabinoids and cancer: pros and cons of an antitumour strategy. 8
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity 8
N6-isopentenyladenosine affects cytotoxic activity and cytokines production by IL-2 activated NK cells and exerts topical anti-inflammatory activity in mice 8
N6-isopentenyladenosine inhibits cell proliferation and induces apoptosis in a human colon cancer cell line DLD1. 8
Increased farnesyltransferase activity in human colorectal cancer: relationship with clinicopathological features and K-ras mutation 8
HMG-CoA reductase inhibitors inhibit rat propylthiouracil-induced goiter by modulating the ras-MAPK pathway 8
Immune-Modulation and Properties of Absorption and Blood Brain Barrier Permeability of 1,8-Naphthyridine Derivatives. 8
Anandamide inhibits the Wnt/?-catenin signalling pathway in human breast cancer MDA MB 231 cells 8
Statins in neurological disorders: An overview and update 8
Astersedifolioside A-C, three new oleane-type saponins with antiproliferative activity 8
Cannabinoid receptor CB1 antagonists state of the art and challenges. 8
Arvanil inhibits T lymphocyte activation and ameliorates autoimmune encephalomyelitis 7
A new strategy to block tumor growth by inhibiting endocannabinoid inactivation 6
N6-isopentenyladenosine inhibits aerobic glycolysis in glioblastoma cells by targeting PKM2 expression and activity 4
N6-Isopentenyladenosine Impairs Mitochondrial Metabolism through Inhibition of EGFR Translocation on Mitochondria in Glioblastoma Cells 4
Lipid homeostasis and mevalonate pathway in COVID-19: Basic concepts and potential therapeutic targets 4
Totale 709
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.301
article - articoli 2.301
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.602
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20248 0 0 0 0 0 0 0 0 2 0 5 1
2024/2025701 5 5 75 45 475 88 8 0 0 0 0 0
Totale 709